Pharmacists in Union, South Carolina


14 Pharmacists found in Union
male pharmacist

Anthony D Esposito


Pharmacist
599 Rice Ave, Union, SC 29379
864-427-7668    

male pharmacist

Mr. Carey Chapman


Pharmacist
528a Rice Ave, Union, SC 29379
864-427-3700     864-427-3900

female pharmacist

Mrs. Crystal W Betenbaugh, BS


Pharmacist
513 N Duncan Byp, Union, SC 29379
864-427-6114     864-427-6444



female pharmacist

Mrs. Crystal Berry Earls


Pharmacist
109 Beechtree Place, Union, SC 29379
864-427-1294    

male pharmacist

Dr. David Clark Hughes, PHARMD


Pharmacist
599 Rice Ave, Union, SC 29379
864-427-7668    

female pharmacist

Mrs. Elizabeth Sailors


Pharmacist
513 N Duncan Byp, Union, SC 29379
864-427-6114    

male pharmacist

Dr. Jason Blake Harrell, PHARMD


Pharmacist
599 Rice Ave, Union, SC 29379
864-427-7668     864-427-1181

male pharmacist

Mr. John M Adkins, RPH


Pharmacist
528a Rice Ave, Union, SC 29379
864-427-3700     864-427-3900

female pharmacist

Julia Bailey, BS


Pharmacist
513 N Duncan Byp, Union, SC 29379
864-427-6114    

male pharmacist

Ken R Black, RPH


Pharmacist
599 Rice Ave, Union, Union, SC 29379
864-427-7668     864-427-1181

female pharmacist

Morgan Morris Revis, PHARMD


Pharmacist
599 Rice Ave, Union, SC 29379
864-427-7668    

female pharmacist

Sonja F Dunbar


Pharmacist
599 Rice Avenue, Union, SC 29379
864-427-7668    

male pharmacist

Stuart Lee Davis, PHARMD


Pharmacist
513 N Duncan Byp, Union, SC 29379
864-427-6114    

male pharmacist

Thomas Littlejohn, RPH


Pharmacist
513 N Duncan Byp, Union, SC 29379
864-427-6114     864-427-6444


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.